Lin Fang

发表

Antitumor activities of an oncolytic adenovirus equipped with a double siRNA targeting Ki67 and hTERT in renal cancer cells.

Kai Xu, Junnian Zheng, Liantao Li, 2014, Virus research.

Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma

Junnian Zheng, J. Chen, Qing Zhang, 2021, Molecular therapy oncolytics.

Complement C1q binding protein regulates T cells’ mitochondrial fitness to affect their survival, proliferation, and anti–tumor immune function

Junnian Zheng, H. Tian, Huizhong Li, 2022, Cancer science.

A novel role mediated by adenoviral E1A in suppressing cancer through modulating decorin

Junnian Zheng, Wen Zhang, J. Shao, 2019, Medical Oncology.

Volatile oil from Saussurea lappa exerts antitumor efficacy by inhibiting epithelial growth factor receptor tyrosine kinase-mediated signaling pathway in hepatocellular carcinoma

Lei Chen, Xuejing Lin, Xiao-hui Fu, 2016, Oncotarget.

An oncolytic adenovirus regulated by a radiation‐inducible promoter selectively mediates hSulf‐1 gene expression and mutually reinforces antitumor activity of I131‐metuximab in hepatocellular carcinoma

Junnian Zheng, Q. Zheng, Quan’an Zhang, 2013, Molecular oncology.

Absent in melanoma 2 enhances anti‐tumour effects of CAIX promotor controlled conditionally replicative adenovirus in renal cancer

Junnian Zheng, H. Tian, Huizhong Li, 2020, Journal of cellular and molecular medicine.

Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma

Jie Yang, Huizhong Li, Gang Wang, 2022, Cancers.

Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment

Junnian Zheng, Wen Zhang, Qian Cheng, 2018, OncoTarget.

A p53-independent apoptotic mechanism of adenoviral mutant E1A was involved in its selective antitumor activity for human cancer

Min Zhao, Junnian Zheng, Liantao Li, 2016, Oncotarget.

Co‐immunization with L‐Myc enhances CD8+ or CD103+ DCs mediated tumor‐specific multi‐functional CD8+ T cell responses

Jie Yang, Junnian Zheng, H. Tian, 2021, Cancer science.

Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors

L. Qin, Junnian Zheng, Gang Wang, 2022, Journal for ImmunoTherapy of Cancer.

The optimization system for preparation of TG1 competent cells and electrotransformation

Junnian Zheng, Huizhong Li, Gang Wang, 2020, MicrobiologyOpen.

Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma.

Chen Zhang, Lin Fang, Junnian Zheng, 2023, Pharmacological research.

Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8+ T-cell Responses

Junnian Zheng, H. Yao, Huizhong Li, 2018, Molecular Cancer Therapeutics.

Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell

Junnian Zheng, Liantao Li, Jie Zhang, 2016, Cancer biology & therapy.

Efficacy of an oncolytic adenovirus driven by a chimeric promoter and armed with Decorin against renal cell carcinoma.

Junnian Zheng, J. Chen, Wen Zhang, 2020, Human gene therapy.

An oncolytic adenovirus expressing interleukin-24 enhances antitumor activities in combination with paclitaxel in breast cancer cells.

Junnian Zheng, Liantao Li, Qian Cheng, 2013, Molecular medicine reports.

Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models

Junnian Zheng, Y. Qiu, Yang Xu, 2014, Oncotarget.

Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma

Junnian Zheng, H. Tian, Huizhong Li, 2021, Translational oncology.

AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction

Junnian Zheng, Huizhong Li, Gang Wang, 2018, Experimental cell research.

Adenovirus vaccine therapy with CD137L promotes CD8+ DCs-mediated multifunctional CD8+ T cell immunity and elicits potent anti-tumor activity.

Jie Yang, Junnian Zheng, Huizhong Li, 2021, Pharmacological research.

H1/pAIM2 nanoparticles exert anti‐tumour effects that is associated with the inflammasome activation in renal carcinoma

Junnian Zheng, H. Yao, Huizhong Li, 2018, Journal of cellular and molecular medicine.

Effects of G250 promoter controlled conditionally replicative adenovirus expressing Ki67‐siRNA on renal cancer cell

Jie Yang, Junnian Zheng, Bao-fu Zhang, 2012, Cancer science.

Mitochondrial C1QBP is essential for T cell antitumor function by maintaining mitochondrial plasticity and metabolic fitness

M. Wang, Junnian Zheng, H. Tian, 2023, Cancer Immunology, Immunotherapy.

Modification of IL‐24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non‐small cell lung cancer

Jie Yang, Junnian Zheng, Huizhong Li, 2019, International immunopharmacology.

Tumor-Penetrating Peptide Enhances Antitumor Effects of IL-24 Against Prostate Cancer

Jie Yang, Junnian Zheng, Qing Zhang, 2018, Translational oncology.

Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors.

M. Wang, Huizhong Li, Gang Wang, 2023, International immunopharmacology.

Recombinant oncolytic adenovirus armed with CCL5, IL-12, and IFN-γ promotes CAR-T infiltration and proliferation in vivo to eradicate local and distal tumors.

Qi Zhang, M. Wang, Jie Yang, 2023, Cell death discovery.

Oncolytic adenovirus-mediated expression of CCL5 and IL12 facilitates CA9-targeting CAR-T therapy against renal cell carcinoma.

Chen Zhang, Lin Fang, Junnian Zheng, 2023, Pharmacological research.

Inhibition of human adenovirus replication by TRIM35-mediated degradation of E1A

Yi Zhang, Gang Wang, Gang Wang, 2023, Journal of virology.